Brazil · Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 39.16 billion. The enterprise value is 46.78 billion.
| Market Cap | 39.16B |
| Enterprise Value | 46.78B |
Important Dates
The last earnings date was Tuesday, November 4, 2025.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | Oct 6, 2025 |
Share Statistics
Raia Drogasil has 1.71 billion shares outstanding. The number of shares has decreased by -1.02% in one year.
| Current Share Class | 1.71B |
| Shares Outstanding | 1.71B |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | +0.30% |
| Owned by Insiders (%) | 20.85% |
| Owned by Institutions (%) | 49.28% |
| Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 28.25 and the forward PE ratio is 24.98. Raia Drogasil's PEG ratio is 1.61.
| PE Ratio | 28.25 |
| Forward PE | 24.98 |
| PS Ratio | 0.93 |
| PB Ratio | 5.59 |
| P/TBV Ratio | 7.95 |
| P/FCF Ratio | 22.93 |
| P/OCF Ratio | 12.59 |
| PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.12, with an EV/FCF ratio of 27.39.
| EV / Earnings | 34.91 |
| EV / Sales | 1.11 |
| EV / EBITDA | 11.12 |
| EV / EBIT | 19.00 |
| EV / FCF | 27.39 |
Financial Position
The company has a current ratio of 1.39, with a Debt / Equity ratio of 1.16.
| Current Ratio | 1.39 |
| Quick Ratio | 0.46 |
| Debt / Equity | 1.16 |
| Debt / EBITDA | 1.94 |
| Debt / FCF | 4.77 |
| Interest Coverage | 2.56 |
Financial Efficiency
Return on equity (ROE) is 20.38% and return on invested capital (ROIC) is 10.59%.
| Return on Equity (ROE) | 20.38% |
| Return on Assets (ROA) | 6.72% |
| Return on Invested Capital (ROIC) | 10.59% |
| Return on Capital Employed (ROCE) | 17.64% |
| Revenue Per Employee | 604,560 |
| Profits Per Employee | 19,184 |
| Employee Count | 64,758 |
| Asset Turnover | 1.85 |
| Inventory Turnover | 3.59 |
Taxes
In the past 12 months, Raia Drogasil has paid 65.94 million in taxes.
| Income Tax | 65.94M |
| Effective Tax Rate | 4.63% |
Stock Price Statistics
The stock price has decreased by -10.25% in the last 52 weeks. The beta is 0.14, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -10.25% |
| 50-Day Moving Average | 19.19 |
| 200-Day Moving Average | 17.66 |
| Relative Strength Index (RSI) | 77.46 |
| Average Volume (20 Days) | 9,279,265 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 42.23 billion and earned 1.34 billion in profits. Earnings per share was 0.81.
| Revenue | 42.23B |
| Gross Profit | 12.39B |
| Operating Income | 2.46B |
| Pretax Income | 1.42B |
| Net Income | 1.34B |
| EBITDA | 3.22B |
| EBIT | 2.46B |
| Earnings Per Share (EPS) | 0.81 |
Balance Sheet
The company has 538.39 million in cash and 8.15 billion in debt, giving a net cash position of -7.61 billion or -4.44 per share.
| Cash & Cash Equivalents | 538.39M |
| Total Debt | 8.15B |
| Net Cash | -7.61B |
| Net Cash Per Share | -4.44 |
| Equity (Book Value) | 7.01B |
| Book Value Per Share | 4.08 |
| Working Capital | 3.88B |
Cash Flow
In the last 12 months, operating cash flow was 3.11 billion and capital expenditures -1.40 billion, giving a free cash flow of 1.71 billion.
| Operating Cash Flow | 3.11B |
| Capital Expenditures | -1.40B |
| Free Cash Flow | 1.71B |
| FCF Per Share | 1.00 |
Margins
Gross margin is 29.33%, with operating and profit margins of 5.83% and 3.17%.
| Gross Margin | 29.33% |
| Operating Margin | 5.83% |
| Pretax Margin | 3.37% |
| Profit Margin | 3.17% |
| EBITDA Margin | 7.63% |
| EBIT Margin | 5.83% |
| FCF Margin | 4.04% |
Dividends & Yields
This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 1.31%.
| Dividend Per Share | 0.30 |
| Dividend Yield | 1.31% |
| Dividend Growth (YoY) | -1.11% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 40.62% |
| Buyback Yield | 1.02% |
| Shareholder Yield | 2.33% |
| Earnings Yield | 3.42% |
| FCF Yield | 4.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 22, 2023. It was a forward split with a ratio of 1.04.
| Last Split Date | May 22, 2023 |
| Split Type | Forward |
| Split Ratio | 1.04 |
Scores
Raia Drogasil has an Altman Z-Score of 3.66 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.66 |
| Piotroski F-Score | 6 |